Literature DB >> 31597994

Common bile duct obstruction palliated with common bile duct re-implantation (choledochoduodenostomy) in a cat.

Galina Hayes1, Sacha Devereux1, John P Loftus1, Mason Jager1, Gerald Duhamel1, Tracy Stokol1.   

Abstract

A cat was presented with complete biliary obstruction at the level of the distal common bile duct (CBD), with loss of normal architecture. The area was excised and submitted for histopathology. Concurrent cholecystitis and gall bladder necrosis necessitated cholecystectomy. The proximal CBD was preserved and re-implanted adjacent to the original duodenal papilla. The cat recovered and remained asymptomatic for 6 months. At clinical relapse a carcinoma of suspected biliary origin was confirmed, and the cat was euthanized. In situations in which the CBD lumen cannot be re-established, the pathology is limited to the distal CBD, and the gall bladder is not available for cholecystoenterostomy, CBD re-implantation may be an option to salvage and retain a functional biliary tree. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Entities:  

Mesh:

Year:  2019        PMID: 31597994      PMCID: PMC6741818     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  14 in total

Review 1.  Single brand, fully-covered, self-expandable metal stent for the treatment of benign biliary disease: when should stents be removed?

Authors:  Benedetto Mangiavillano; Mouen A Khashab; Leonardo H Eusebi; Ilaria Tarantino; Mario Bianchetti; Rossella Semeraro; Rinaldo Pellicano; Mario Traina; Alessandro Repici
Journal:  Minerva Gastroenterol Dietol       Date:  2018-05-31

2.  A mucosal apposition technique for ureteroneocystostomy after renal transplantation in cats.

Authors:  C R Gregory; R A Lirtzman; E J Kochin; R L Rooks; D L Kobayashi; R Seshadri; D Scott
Journal:  Vet Surg       Date:  1996 Jan-Feb       Impact factor: 1.495

3.  Cholecystoenterostomy for treatment of extrahepatic biliary tract obstruction in cats: 22 cases (1994-2003).

Authors:  Nicole J Buote; Susan L Mitchell; Dominique Penninck; Lisa M Freeman; Cynthia R L Webster
Journal:  J Am Vet Med Assoc       Date:  2006-05-01       Impact factor: 1.936

4.  Primary sclerosing cholangitis successfully treated by resection of the confluence of the hepatic duct.

Authors:  I Hirai; S Ishiyama; A Fuse; H Kuzu; F Sakurai; S Kimura; W Kimura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2001

5.  Late development of bile duct cancer in patients who had biliary-enteric drainage for benign disease: a follow-up study of more than 1,000 patients.

Authors:  A Tocchi; G Mazzoni; G Liotta; L Lepre; D Cassini; M Miccini
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

6.  Choledochotomy and primary repair of extrahepatic biliary duct rupture in seven dogs and two cats.

Authors:  S G Baker; P D Mayhew; S J Mehler
Journal:  J Small Anim Pract       Date:  2010-12-09       Impact factor: 1.522

7.  Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study.

Authors:  A Aziz Aadam; Douglas B Evans; Abdul Khan; Young Oh; Kulwinder Dua
Journal:  Gastrointest Endosc       Date:  2012-04-05       Impact factor: 9.427

8.  Choledochal tube stenting for decompression of the extrahepatic portion of the biliary tract in dogs: 13 cases (2002-2005).

Authors:  Philipp D Mayhew; Robert W Richardson; Stephen J Mehler; David E Holt; Chick W Weisse
Journal:  J Am Vet Med Assoc       Date:  2006-04-15       Impact factor: 1.936

9.  A prospective, randomized clinical investigation of cholecystoenterostomy and choledochoenterostomy.

Authors:  I J Sarfeh; E B Rypins; J G Jakowatz; G L Juler
Journal:  Am J Surg       Date:  1988-03       Impact factor: 2.565

10.  A comparison of cholecysto- and choledochoenterostomy for obstructing pancreatic cancer.

Authors:  M D Rappaport; M Villalba
Journal:  Am Surg       Date:  1990-07       Impact factor: 0.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.